| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |